Global Gelatin Polypeptide Plasma Expander Market Size By Type (4.0% Content, 3.5% Content), By Application (Preoperative prevention, Extracorporeal circulation and dialysis), By Region, And Segment F...

The Global Gelatin Polypeptide Plasma Expander Market was valued at USD 1.1 billion in 2023 and is projected to reach USD 1.9 billion by 2031, growing at a CAGR of 7.0% during the forecast period from 2023 to 2031. The increasing incidence of trauma cases, surgical procedures, and emergency care demand has been a key factor in the growth of plasma expanders. Gelatin-based plasma expanders are favored due to their biocompatibility, low immunogenicity, and efficacy in maintaining hemodynamic stability. Their widespread application in hospitals, military medicine, and emergency care units continues to support the market's expansion.

Drivers:

Rising Surgical and Trauma Cases:

The increasing frequency of surgeries, critical care treatments, and trauma interventions globally is boosting demand for plasma expanders like gelatin polypeptides that restore blood volume quickly and effectively.

Advancements in Plasma Expander Formulations:

Continued innovation in gelatin derivatives and safer, more effective formulations is encouraging broader clinical use, especially in settings requiring rapid intravascular volume replacement.

Expansion of Emergency and Critical Care Infrastructure:

Globally, health systems are enhancing emergency response capabilities, particularly in developing regions. This creates a fertile environment for plasma expander adoption in both civilian and military healthcare systems.

Restraints:

Availability of Alternatives:

The presence of other plasma expanders, such as hydroxyethyl starch (HES) and crystalloids, poses competition, especially in markets where cost sensitivity is a concern.

Adverse Reactions and Regulatory Scrutiny:

Although relatively safe, gelatin polypeptides may cause allergic reactions in some patients. Additionally, evolving regulatory frameworks for blood and plasma products may restrict use under certain conditions.

Opportunity:

Growing Adoption in Developing Healthcare Systems:

As emerging economies enhance access to surgical care and trauma management, demand for cost-effective and stable plasma expanders is anticipated to surge.

Innovation in Hybrid and Synthetic Formulations:

R&D in combining gelatin-based products with other biologics or synthetic agents could result in next-gen expanders with enhanced efficacy and safety profiles, offering market expansion avenues.

Market by System Type Insights:

Based on system type, Modified Fluid Gelatin held the dominant share in 2023 due to its high compatibility and rapid volume expansion capabilities. These are widely used during surgeries and emergencies to manage acute blood loss. However, Urea-Linked Gelatin is anticipated to grow at the fastest rate during the forecast period, attributed to its lower anaphylactic potential and longer intravascular retention.

Market by End-use Insights:

Hospitals emerged as the largest end-use segment in 2023, accounting for over 60% of the revenue share. Their centralized emergency and surgical facilities drive demand for gelatin plasma expanders. Meanwhile, military and field hospitals are gaining momentum as modern battlefield medical logistics increasingly rely on rapid-response plasma expanders for trauma care.

Market by Regional Insights:

In 2023, Europe led the global market, attributed to strong healthcare systems, high surgical volumes, and long-standing adoption of gelatin-based medical products. Asia-Pacific is expected to witness the fastest growth during the forecast period, driven by improvements in trauma care infrastructure, increased surgical procedures, and growing investments in healthcare in countries such as China and India.

Competitive Scenario:

Key players in the global gelatin polypeptide plasma expander market include B. Braun Melsungen AG, Fresenius SE & Co. KGaA, Baxter International Inc., Pfizer Inc., Grifols S.A., CSL Behring, and Terumo Corporation. Companies are focused on strategic collaborations, regulatory approvals, and regional expansion. For example:

In 2023, B. Braun launched a next-generation gelatin-based volume expander designed for improved thermal stability and longer shelf life.

In 2024, Fresenius received approval in Japan for its new urea-linked gelatin solution, targeting improved emergency care applications.

Scope of Work – Global Gelatin Polypeptide Plasma Expander Market

Report Metric Details

Market Size (2023) USD 1.1 billion

Projected Market Size (2031) USD 1.9 billion

CAGR (2023–2031) 7.0%

Market Segments By System Type (Modified Fluid Gelatin, Urea-Linked Gelatin),

By End-use (Hospitals, Military, Clinics),

By Region (North America, Europe, Asia-Pacific, Latin America, MEA)

Growth Drivers Increase in surgeries and trauma cases, rising critical care demand, advancements in formulations

Opportunities Expansion in developing markets, hybrid product innovations

Key Market Developments:

March 2023: Baxter launched a cost-effective gelatin plasma expander aimed at public hospitals in Southeast Asia.

July 2024: Pfizer began a Phase II trial of a novel gelatin hybrid plasma expander designed for trauma-induced hypovolemia.

January 2025: Terumo Corporation entered a strategic partnership with a military medical research body to co-develop rapid-infusion gelatin plasma expanders.

FAQs:

What is the current market size of the Global Gelatin Polypeptide Plasma Expander Market?

The market was valued at USD 1.1 billion in 2023.

What is the major growth driver of the Global Gelatin Polypeptide Plasma Expander Market?

The rising number of trauma cases and surgical procedures requiring rapid volume expansion is the primary driver.

Which is the largest region during the forecast period in the Global Gelatin Polypeptide Plasma Expander Market?

Europe held the largest share in 2023, while Asia-Pacific is expected to grow the fastest.

Which segment accounted for the largest market share in the Global Gelatin Polypeptide Plasma Expander Market?

The Modified Fluid Gelatin segment dominated the market in 2023.

Who are the key market players in the Global Gelatin Polypeptide Plasma Expander Market?

Key players include B. Braun, Fresenius, Baxter, Pfizer, Grifols, CSL Behring, and Terumo Corporation.